![BioTech Gate](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/835/normal/Screen_Shot_2016-01-27_at_11.07.21.png?1453892866)
UCLA and Caltech Study Uses Technology Being Commercialized by IsoPlexis To Characterize Cancer Cells Resistant to Targeted Treatments
BioTech Gate,
BRANFORD, Conn., Dec. 14, 2017 /PRNewswire-USNewswire/ -- Researchers from Caltech and UCLA used novel single-cell…